Study sample collection for sepsis and after cardiac arrest
Part of Heart & circulation, Infections clinical trials.
This trial collects and stores small samples from people in the ICU who are either being treated for sepsis or who have survived a non-traumatic cardiac arrest. It may help researchers better understand how the body changes after severe infection or after revival, which could improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 16 or older
- Be admitted to the ICU (intensive care unit)
- Be diagnosed with sepsis, or be in the post-resuscitation period after surviving a non-traumatic cardiac arrest
- Have a confirmed or strongly suspected infection for sepsis (often alongside specific body-response signs)
- Be willing to participate
- Not have a DNAR order (do-not-attempt-resuscitation)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
This trial is a registry, which means the researchers collect information about people who were treated in an intensive care unit after a cardiac arrest. It may help improve understanding of outcomes and care, which can guide future treatment.
This trial looks at natural molecules that help the body resolve severe infections. Researchers want to understand how these molecules affect recovery and identify patient types that respond best. It may help improve treatment for people in the ICU with serious infections.
This study tests a new, timely approach to managing sepsis (a severe infection that can harm the body). It aims to improve care in the Emergency Department and Intensive Care Unit, which could help patients recover faster.
This trial looks at how the body’s inflammation response behaves after someone has a cardiac arrest and was treated in the ICU. It may help doctors understand which patients could benefit from treatments that target harmful inflammation after resuscitation.
This trial studies treatments for sepsis, a serious infection complication, in ICU patients. It aims to find better ways to care for critically ill patients with sepsis.
Hear when a new Cardiac Arrest trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.